EP1027046A4 - Antagonistes de l'hormone de liberation de la gonadothrophine - Google Patents

Antagonistes de l'hormone de liberation de la gonadothrophine

Info

Publication number
EP1027046A4
EP1027046A4 EP98954019A EP98954019A EP1027046A4 EP 1027046 A4 EP1027046 A4 EP 1027046A4 EP 98954019 A EP98954019 A EP 98954019A EP 98954019 A EP98954019 A EP 98954019A EP 1027046 A4 EP1027046 A4 EP 1027046A4
Authority
EP
European Patent Office
Prior art keywords
antagonists
releasing hormone
gonadotropin releasing
gonadotropin
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98954019A
Other languages
German (de)
English (en)
Other versions
EP1027046A1 (fr
Inventor
Lin Chu
Mark T Goulet
Thomas F Walsh
Stephanie L Witkin
Matthew J Wyvratt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9809789.2A external-priority patent/GB9809789D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1027046A1 publication Critical patent/EP1027046A1/fr
Publication of EP1027046A4 publication Critical patent/EP1027046A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP98954019A 1997-10-28 1998-10-27 Antagonistes de l'hormone de liberation de la gonadothrophine Withdrawn EP1027046A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6330597P 1997-10-28 1997-10-28
GB9809789 1998-05-07
GBGB9809789.2A GB9809789D0 (en) 1998-05-07 1998-05-07 Antagonists of gonadotropin releasing hormone
PCT/US1998/022799 WO1999021553A1 (fr) 1997-10-28 1998-10-27 Antagonistes de l'hormone de liberation de la gonadothrophine
US63305P 2008-01-31

Publications (2)

Publication Number Publication Date
EP1027046A1 EP1027046A1 (fr) 2000-08-16
EP1027046A4 true EP1027046A4 (fr) 2002-04-03

Family

ID=26313619

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98954019A Withdrawn EP1027046A4 (fr) 1997-10-28 1998-10-27 Antagonistes de l'hormone de liberation de la gonadothrophine

Country Status (5)

Country Link
EP (1) EP1027046A4 (fr)
JP (1) JP2001520996A (fr)
AU (1) AU1124399A (fr)
CA (1) CA2308454A1 (fr)
WO (1) WO1999021553A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0017256D0 (en) 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0022670D0 (en) 2000-09-15 2000-11-01 Astrazeneca Ab Molecules
SE0100566D0 (sv) 2001-02-20 2001-02-20 Astrazeneca Ab Compounds
SE0101692D0 (sv) * 2001-05-14 2001-05-14 Astrazeneca Ab Compounds
TW200413351A (en) 2002-08-21 2004-08-01 Astrazeneca Ab Chemical compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
DE60318716T2 (de) 2002-08-21 2009-01-08 Astrazeneca Ab Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
GB0219472D0 (en) 2002-08-21 2002-10-02 Astrazeneca Ab Chemical compounds
DE60314158T2 (de) 2002-08-21 2008-01-31 Astrazeneca Ab Pyrazolderivate als gnrh-inhibitoren
MXPA06014018A (es) 2004-06-01 2007-02-08 Hoffmann La Roche 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas.
DE102004033902A1 (de) 2004-07-14 2006-02-16 Zentaris Gmbh Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's)
JP2009517432A (ja) 2005-11-30 2009-04-30 エフ．ホフマン−ラ ロシュ アーゲー ３−アミノ−２−アリールプロピルアザインドールおよびその使用
ES2368416T3 (es) 2005-11-30 2011-11-17 F. Hoffmann-La Roche Ag Procedimiento para la síntesis de 3-amino-1-arilpropil-indoles.
RU2008120138A (ru) 2005-11-30 2010-01-10 Ф. Хоффманн-Ля Рош Аг (Ch) 3-амино-1-арилпропилиндолы и аза-замещенные индолы
EP2095818A1 (fr) 2008-02-29 2009-09-02 AEterna Zentaris GmbH Utilisation d'antagonistes LHRH dans des doses n'impliquant pas de castration
US8378107B2 (en) 2008-10-01 2013-02-19 Panmira Pharmaceuticals, Llc Heteroaryl antagonists of prostaglandin D2 receptors
EP2968566A1 (fr) * 2013-03-15 2016-01-20 AbbVie Inc. Compositions utiles pour traiter les règles abondantes et les fibromes
US20170158702A1 (en) * 2015-12-02 2017-06-08 Kyras Therapeutics, Inc. Multivalent ras binding compounds
AU2019353144B2 (en) 2018-10-05 2023-11-16 Annapurna Bio, Inc. Compounds and compositions for treating conditions associated with APJ receptor activity

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181559A1 (en) * 1972-04-28 1973-12-07 Aec Chimie Organique Bio N-Phenylalkyl-N-3-indolylalkyl-alkylamines - with sedative, neuroleptic, analgesic, hypotensive, antiserotonin, adrenolytic activity
GB1562825A (en) * 1975-10-29 1980-03-19 Lilly Co Eli N-(2-(5-methoxa-6-halo-indol-3-yl)-ethyl)-amides methods for their preparation and their use
US4544663A (en) * 1984-05-07 1985-10-01 Sandoz, Inc. Indolamine derivatives as anti-fertility agents
US5030640A (en) * 1989-01-05 1991-07-09 Merck & Co., Inc. Novel β-adrenergic agonists and pharmaceutical compositions thereof
WO1998055119A1 (fr) * 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonistes de l'hormone de liberation de la gonadotrophine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
US5756507A (en) * 1995-12-14 1998-05-26 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
CA2240108A1 (fr) * 1995-12-14 1997-06-19 Peter Lin Antagonistes de l'hormone de liberation de la gonadotropine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181559A1 (en) * 1972-04-28 1973-12-07 Aec Chimie Organique Bio N-Phenylalkyl-N-3-indolylalkyl-alkylamines - with sedative, neuroleptic, analgesic, hypotensive, antiserotonin, adrenolytic activity
GB1562825A (en) * 1975-10-29 1980-03-19 Lilly Co Eli N-(2-(5-methoxa-6-halo-indol-3-yl)-ethyl)-amides methods for their preparation and their use
US4544663A (en) * 1984-05-07 1985-10-01 Sandoz, Inc. Indolamine derivatives as anti-fertility agents
US5030640A (en) * 1989-01-05 1991-07-09 Merck & Co., Inc. Novel β-adrenergic agonists and pharmaceutical compositions thereof
WO1998055119A1 (fr) * 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonistes de l'hormone de liberation de la gonadotrophine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9921553A1 *

Also Published As

Publication number Publication date
EP1027046A1 (fr) 2000-08-16
JP2001520996A (ja) 2001-11-06
WO1999021553A1 (fr) 1999-05-06
CA2308454A1 (fr) 1999-05-06
AU1124399A (en) 1999-05-17

Similar Documents

Publication Publication Date Title
EP0986385A4 (fr) Antagonistes de gonadoliberine
EP0986557A4 (fr) Antagonistes de la gonadoliberine
IL124554A0 (en) Antagonists of gonadotropin releasing hormone
IL124613A0 (en) Antagonists of gonadotropin releasing hormone
EP0868178A4 (fr) Antagonistes de la gonadoliberine
EP0918522A4 (fr) Antagonistes de la gonadoliberine
AU3008997A (en) Antagonists of gonadotropin releasing hormone
ZA9610535B (en) Antagonists of gonadotropin releasing hormone.
ZA9610536B (en) Antagonists of gonadotropin releasing hormone.
EP1011667A4 (fr) Antagonistes de l'hormone de liberation de la gonadotrophine
EP1067930A4 (fr) Antagonistes de l'hormone liberant la gonadotropine (gnrh)
EP1027046A4 (fr) Antagonistes de l'hormone de liberation de la gonadothrophine
EP0901471A4 (fr) Antagonistes de la gonadoliberine
EP0920319A4 (fr) Antagonistes de la gonadoliberine
EP1049472A4 (fr) Antagonistes de la gonadoliberine
AU4834900A (en) Antagonists of gonadotropin releasing hormone
EP1062215A4 (fr) Antagonistes de l'hormone de liberation de la gonadotrophine
GB9719840D0 (en) Antagonists of gonadotropin releasing hormone
GB9719386D0 (en) Antagonists of gonadotropin releasing hormone
GB9719387D0 (en) Antagonists of gonadotropin releasing hormone
GB9719391D0 (en) Antagonists of gonadotropin releasing hormone
GB9603242D0 (en) Antagonists of gonadotropin releasing hormone
GB9612084D0 (en) Antagonists of gonadotropin releasing hormone
GB9603344D0 (en) Antagonists of gonadotropin releasing hormone
GB9603369D0 (en) Antagonists of gonadotropin releasing hormone

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000529

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20000529;LT PAYMENT 20000529;LV PAYMENT 20000529;MK PAYMENT 20000529;RO PAYMENT 20000529;SI PAYMENT 20000529

A4 Supplementary search report drawn up and despatched

Effective date: 20020219

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/405 A, 7A 61K 31/35 B, 7C 07D 209/04 B, 7C 07D 209/14 B, 7C 07D 209/42 B, 7A 61P 5/24 B, 7C 07D 453/06 B, 7C 07D 487/08 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020503